| > | > Myriad Assures Investors of Strong Patent Position Despite ACLU Anti-Gene …
GenomeWeb Daily News Specifically, the lawsuit challenges the patentability and constitutionality of Myriad's patents on the BRCA1 and BRCA2 genes, linked to increased … |
You must log in to post a comment.